| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| ALKS | Alkermes plc. | Director and CEO, Alkermes plc, Director | $47.9M | Feb 19, 2025 | ||
| NBIX | NEUROCRINE BIOSCIENCES INC | Director | $4.05M | May 21, 2025 |
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|